| Record ID | harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:398421371:1160 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:398421371:1160?format=raw |
LEADER: 01160cam a22003858a 4500
001 013349374-1
005 20120913162907.0
008 100701s2011 ne a 000 0 eng
015 $aGBB080553$2bnb
016 7 $a015594196$2Uk
020 $a9780123849649 (hbk.)
020 $a0123849640 (hbk.)
035 0 $aocn646393829
040 $aUKM$cUKM$dYDXCP$dLTSCA$dOHS$dCOD
050 4 $aRS380$b.M57 2011
082 04 $a615.19$222
245 00 $aChallenges in delivery of therapeutic genomics and proteomics /$cedited by Ambikanandan Misra.
250 $a1st ed.
260 $aAmsterdam ;$aBoston :$bElsevier,$c2011.
300 $axiv, 671 p. :$bill. ;$c24 cm.
490 1 $aElsevier insights
504 $aIncludes bibliographical references.
650 2 $aPharmacogenetics.
650 2 $aGenomics$xmethods.
650 2 $aDrug Design.
650 2 $aDrug Delivery Systems.
650 0 $aPharmaceutical biotechnology.
650 0 $aPharmacogenomics.
650 0 $aProtein drugs$xDesign.
650 0 $aDrug delivery systems.
700 1 $aMisra, Ambikanandan.
830 0 $aElsevier insights.
988 $a20120913
049 $aHMSS
906 $0OCLC